Name: 18th European Diabetes and Endocrinology Congress
Start: 2025-03-10
End: 2025-03-11
Location: Dubai, UAE

Diabetes Conference, Diabetes Conferences, Diabetes congress, Endocrine Disorders, Diabetes Congress, Diabetes Type1, Diabetes Type2, Euro Endocrinology 2023, Diabetes, Diabetes Treatment

Renowned Speakers

Viola Pomozi

Research Centre for Natural Sciences Hungary

Shigehiro Katayama

Saitama Medical University Japan

Nicolae Hancu

Luliu Hatieganu University of Medicine Romania

John Yfantopoulos

University of Athens Greece

Joseph Fomusi

Ndisang Associate Professor Canada

Marc Baget

University Rovira I Virgili Spain

Masao Kaneki

Harvard Medical School USA

Amnah A1-Sayyar

Dasman Diabetes Institute Kuwait

Recommended Global Diabetes & Endocrinology Webinars & Conferences

Europe & UK

Addiction Congress 2024, Switzerland Euro Endocrinology 2025, Italy Euro Cancer 2024, Italy Agriculture 2024, Netherlands

Asia Pacific & Middle East

Biodiesel 2024, UAE Dentists 2025, UAE Drug Devilvery 2024, UAE Stress 2025, Thailand

Canada

Diabetes Meeting 2025, Canada CAM 2024, Canada Cancer Drugs 2024, Canada

Euro Endocrinology 2025

About Conference

Welcome to the 18^th European Diabetes and Endocrinology Congress (Euro Endocrinology 2025). It's a one-of-a-kind event showcasing the numerous angles and diversity of diabetes and endocrinology. All Over the world diabetes doctors, professionals, nursers and healthcare experts are anticipated to attend the two- days conference.

Medical doctors, cases, and health care providers consider the prevention of endocrine diseases as an essential tool to ameliorate the general health status of the population. According to a recent statistical check, the proportion of people suffering from the complaint are anticipated to increase in the future. Realizing this imperative, Conference Series is set to organize 18^th European Diabetes and Endocrinology Congress to be held during March 10-11, 2025 in Rome, Italy with a view to promote mindfulness and enhance exploration aiming in developing results for the challenges encountered.

Organizing Committee invites the actors from each over the globe to take part in this periodic flagship conference with the theme “Current Trends, Novel Innovations and Advances in Diabetes Management”. Euro Endocrinology 2025 will concentrate on the ultimate and instigative inventions in all areas of Diabetes and Endocrinology exploration and aims to publish knowledge and share new ideas amongst Endocrinologists, Diabetes experience, Researchers, Professors, Scientific communities, Counselors, Delegates, Scholars, Business Professionals, and Directors. The Conference will have space for institutions and/ or companies to present their services, products, inventions and exploration results.

In support of perfecting patient care, this exertion has been planned and enforced by Conference Series Llc Ltd and Center for Education Development (CED). CED is concertedly accredited by the Accreditation Council for Pharmacy Education (ACPE), the Accreditation Council for Continuing Medical Education (ACCME) and the American Nursers Credentialing Center (ANCC), to give continuing education for the healthcare platoon.

Target Audience :

Diabetologists

Endocrinologists

Doctors

Researchers

Physicians

Business Professionals

Academic Professionals

Scholars

Scientists

Medical and Pharma Companies

Medical Colleges and Hospitals

Diabetes Societies and Associations

WHY ATTEND ???

The Euro Endocrinology 2025 aims to create awareness and convey medical skills about new technologies on diabetes.

Walk for the CURE

Can get recent innovation ideas on diabetes curable medicine

Can grow B2B networking between business professional, endocrinologists and diabetes institutes.

Can exhibit new ideas and can visit our valuable exhibition booth

Can sponsor Euro Endocrinology 2023 with Diamond, Gold and Silver opportunity

Can showcase your most advanced ideas through Oral/Poster/Video

Get motivated by experts on Diabetes

Can unite with diabetes and endocrinology specialists at Rome

Can listen all the research communication through Physical and Virtual

Can have panel discussions and interactive sessions

Best Poster presentation award by choosing their crisp ideas by OCM

Providing Young Research Forum award to motivate student researchers

Update the business with novel techniques to benefit your research

Sessions/Tracks

Track-01: Diabetes

Diabetes is a chronic condition that affects how the body processes blood sugar (glucose). There are two main types: Type 1, where the pancreas produces little to no insulin, and Type 2, where the body becomes resistant to insulin or doesn’t produce enough. Symptoms include increased thirst, frequent urination, fatigue, and blurred vision. Managing diabetes involves lifestyle changes like a balanced diet, regular exercise, and monitoring blood sugar levels. Medication or insulin therapy may also be required. Long-term complications can include heart disease, kidney damage, and nerve issues. Awareness and education are crucial for prevention and management, making regular check-ups and healthy habits essential for those at risk or diagnosed with the condition.

Track-02: Endocrinology

Endocrinology is the branch of medicine focused on the endocrine system, which includes glands that secrete hormones regulating various bodily functions. These hormones influence metabolism, growth, reproduction, and mood. Key glands include the pituitary, thyroid, adrenal glands, and pancreas. Endocrinologists diagnose and treat hormonal imbalances and disorders, such as diabetes, thyroid diseases, adrenal insufficiency, and polycystic ovary syndrome (PCOS). Patients may experience symptoms like fatigue, weight changes, and fertility issues, necessitating careful evaluation and tailored treatment plans. Advances in endocrinology have improved understanding of hormonal interactions and led to innovative therapies. Regular check-ups and a healthy lifestyle play crucial roles in managing endocrine health and preventing complications associated with hormonal disorders.

Track-03: Type 1 Diabetes

Type 1 diabetes is a chronic autoimmune condition where the immune system mistakenly attacks insulin-producing beta cells in the pancreas. This leads to little or no insulin production, making it challenging for the body to regulate blood sugar levels. Common symptoms include excessive thirst, frequent urination, extreme fatigue, and unintended weight loss. Diagnosis typically occurs in children and young adults, but it can develop at any age. Managing Type 1 diabetes involves lifelong insulin therapy, regular blood sugar monitoring, and a balanced diet. Patients often use insulin pumps or injections to maintain optimal glucose levels. Continuous education and support are vital for navigating the daily challenges of the condition, helping to prevent long-term complications like cardiovascular disease and nerve damage.

Track-04: Pediatric Endocrinology

Pediatric endocrinology is a specialized field focused on diagnosing and treating hormone-related disorders in children and adolescents. This branch of medicine addresses conditions such as diabetes, growth disorders, thyroid issues, and puberty-related problems. Pediatric endocrinologists work closely with young patients to manage conditions like Type 1 diabetes, ensuring proper insulin therapy and education for families. They also assess growth patterns to identify potential endocrine disorders early, promoting healthy development. Managing hormonal imbalances in children is crucial, as these can significantly impact physical and emotional well-being. A comprehensive approach often involves collaboration with other specialists, nutritionists, and psychologists to provide holistic care. Early intervention and ongoing support are essential for optimizing health outcomes and quality of life for young patients.

Track-05: Type 2 Diabetes

Type 2 diabetes is a chronic condition characterized by insulin resistance, where the body does not effectively use insulin, or inadequate insulin production. It typically develops in adults, but increasing rates are seen in children and adolescents due to rising obesity levels. Symptoms include increased thirst, frequent urination, fatigue, and blurred vision, though many individuals may remain asymptomatic initially. Risk factors include obesity, sedentary lifestyle, and genetic predisposition. Managing Type 2 diabetes involves lifestyle changes such as a balanced diet, regular exercise, and weight management. Medications may also be prescribed to help control blood sugar levels. Early diagnosis and intervention are crucial to prevent complications like heart disease, kidney damage, and nerve issues, improving overall quality of life.

Track-06: Diabetic Nutrition and Diet

Diabetic nutrition and diet play a crucial role in managing blood sugar levels for individuals with diabetes. A balanced diet focuses on whole foods, including vegetables, fruits, whole grains, lean proteins, and healthy fats. Carbohydrate counting is essential, as it helps regulate blood glucose levels; portion control and meal timing are also important. Foods with a low glycemic index are preferred, as they cause slower, more stable increases in blood sugar. Regular meals and snacks can prevent spikes and dips in glucose levels. Additionally, staying hydrated and limiting processed foods, added sugars, and saturated fats are vital for overall health. Collaborating with a registered dietitian can help create personalized meal plans, enhancing diabetes management and improving quality of life.

Track-07: Thyroid Disorders

Thyroid disorders involve imbalances in hormone production by the thyroid gland, which regulates metabolism, energy, and growth. The two most common conditions are hypothyroidism, where the gland underproduces hormones, leading to fatigue, weight gain, and depression, and hyperthyroidism, characterized by excessive hormone production, causing weight loss, anxiety, and rapid heart rate. Other disorders include goiter (enlargement of the thyroid) and thyroiditis (inflammation). Diagnosis typically involves blood tests measuring thyroid hormone levels and antibodies. Treatment options vary based on the condition; hypothyroidism is usually managed with hormone replacement therapy, while hyperthyroidism may require medication, radioactive iodine, or surgery. Regular monitoring is essential to prevent complications and ensure optimal thyroid health and overall well-being.

Track-08: Obesity Treatment

Obesity treatment focuses on achieving and maintaining a healthy weight to reduce associated health risks, including diabetes, heart disease, and certain cancers. Approaches typically include lifestyle modifications such as a balanced diet and regular physical activity. Behavioral therapy can also support changes in eating habits and activity levels. In cases where lifestyle changes are insufficient, medications may be prescribed to aid weight loss by suppressing appetite or increasing feelings of fullness. Surgical options, such as bariatric surgery, may be considered for individuals with severe obesity or related health conditions. Ongoing support, including regular check-ups and counseling, is crucial for sustaining weight loss and improving overall health. Personalized treatment plans tailored to individual needs enhance long-term success.

Track-09: Endocrine Disorders

Endocrine disorders involve imbalances in hormone production and regulation, affecting various bodily functions. Common disorders include diabetes, where insulin production is impaired, leading to high blood sugar levels; hypothyroidism, characterized by insufficient thyroid hormone leading to fatigue and weight gain; and hyperthyroidism, with excessive hormone production causing weight loss and anxiety. Other conditions include adrenal insufficiency, polycystic ovary syndrome (PCOS), and growth disorders. Diagnosis often involves blood tests to measure hormone levels and assess gland function. Treatment varies depending on the specific disorder, including hormone replacement therapy, medications, or lifestyle changes. Early diagnosis and management are essential to prevent complications and improve the quality of life for individuals affected by these conditions. Regular monitoring is crucial for effective management.

Track-10: Diabetes Management Innovations

Diabetes management has seen remarkable innovations in recent years, significantly improving patient outcomes. Continuous glucose monitoring (CGM) systems allow individuals to track blood sugar levels in real-time, providing insights that lead to better dietary and lifestyle choices. Insulin delivery systems have also evolved, with automated insulin pumps and hybrid closed-loop systems adjusting insulin doses based on CGM data. Digital health platforms and mobile apps enable personalized management plans, fostering patient engagement and adherence. Additionally, advancements in telemedicine have made consultations more accessible, allowing for timely interventions. Emerging technologies like artificial intelligence and machine learning are poised to enhance predictive analytics, further refining management strategies. These innovations empower patients, promote better glycemic control, and reduce the long-term complications associated with diabetes.

Track-11: Neuroendocrinology

Neuroendocrinology is the study of the interactions between the nervous system and the endocrine system, focusing on how hormones influence brain function and behavior. This interdisciplinary field explores the roles of various hormones, such as cortisol, adrenaline, and oxytocin, in regulating physiological processes like stress response, metabolism, and reproductive functions. Key areas of research include the hypothalamus and pituitary gland, which serve as critical hubs for hormonal regulation. Neuroendocrinology also examines how external factors, such as environment and social interactions, impact hormone levels and, consequently, behavior and mental health. Understanding these connections has important implications for treating disorders like depression, anxiety, and metabolic syndromes, highlighting the complex interplay between mind and body.

Track-12: Diabetes Prevention

Diabetes prevention is crucial in addressing the rising prevalence of this chronic condition. Key strategies include promoting healthy lifestyle changes, such as regular physical activity, balanced nutrition, and weight management. Community programs that encourage exercise and offer nutritional education play a significant role in reducing risk factors. Screening for prediabetes allows early intervention, where lifestyle modifications can prevent or delay the onset of type 2 diabetes. Additionally, support from healthcare providers, including personalized advice and motivation, is essential. Innovations in technology, like health apps and wearables, help individuals track their progress and stay engaged. By fostering awareness and implementing preventive measures, we can significantly reduce diabetes incidence and enhance overall public health.

Track-13: Diabetes Treatments

Diabetes treatments aim to manage blood sugar levels and prevent complications. Type 1 diabetes typically requires insulin therapy, where patients inject insulin or use an insulin pump to mimic natural hormone release. Type 2 diabetes often starts with lifestyle changes, such as a balanced diet and regular exercise. If necessary, oral medications like metformin or GLP-1 receptor agonists may be prescribed to improve insulin sensitivity or stimulate insulin production. Continuous glucose monitoring systems can help patients track their levels in real time. In some cases, advanced treatments like bariatric surgery or even pancreatic transplants are considered. Regular check-ups are crucial for monitoring overall health and adjusting treatment plans as needed. A multidisciplinary approach enhances effectiveness and quality of life.

Track-14: Gestational Diabetes

Gestational diabetes is a form of diabetes that develops during pregnancy, typically affecting women in their second or third trimester. It occurs when the body cannot produce enough insulin to meet increased demands, leading to elevated blood sugar levels. Risk factors include obesity, a history of diabetes, and age over 25. Common symptoms may include increased thirst and frequent urination, but many women experience no symptoms. Managing gestational diabetes involves monitoring blood sugar levels, following a balanced diet, and engaging in regular physical activity. In some cases, insulin or medication may be necessary. Most women see their blood sugar levels return to normal after childbirth, but they remain at higher risk for developing type 2 diabetes later in life. Regular follow-up is essential.

Track-15: Hormonal Replacement Therapy

Hormonal Replacement Therapy (HRT) involves administering hormones to alleviate symptoms associated with hormonal imbalances, particularly during menopause in women. It aims to reduce symptoms such as hot flashes, night sweats, and mood swings by supplementing estrogen and progesterone levels. HRT can improve quality of life but comes with potential risks, including increased chances of blood clots, heart disease, and certain cancers.

Patients are encouraged to consult healthcare providers to weigh the benefits and risks based on individual health profiles. Various forms of HRT are available, including pills, patches, and gels, allowing for personalized treatment options. Monitoring and regular check-ups are essential to ensure safety and effectiveness, making HRT a tailored approach to managing hormonal changes.

Track-16: Bone Health

Bone health is crucial for overall well-being, as strong bones provide support, protect organs, and facilitate movement. Key factors influencing bone health include nutrition, physical activity, and lifestyle choices. Calcium and vitamin D are essential nutrients that help build and maintain bone density, while weight-bearing exercises strengthen bones and improve balance.

A healthy lifestyle, including avoiding smoking and excessive alcohol consumption, also contributes to better bone health. Osteoporosis, a condition characterized by weakened bones, increases the risk of fractures, particularly in older adults. Regular check-ups and bone density tests can help identify risks early. By prioritizing a balanced diet, exercise, and healthy habits, individuals can significantly enhance their bone health and reduce the likelihood of related complications.

Track-17: Endocrine Cancer

Endocrine cancer refers to malignancies that originate in the hormone-producing glands of the endocrine system, such as the thyroid, adrenal glands, and pancreas. These cancers can disrupt hormone production, leading to various health issues. Common types include thyroid cancer, adrenal carcinoma, and pancreatic neuroendocrine tumors. Symptoms may vary based on the gland affected but often include unexplained weight changes, hormonal imbalances, and abdominal pain.

Diagnosis typically involves imaging tests, biopsies, and hormone level assessments. Treatment options may include surgery, radiation therapy, and targeted therapies, depending on the cancer type and stage. Early detection is crucial for improved outcomes, making awareness of risk factors, family history, and regular check-ups essential for effective management of endocrine cancers.

Track-18: Circadian Rhythms

Circadian rhythms are natural, internal processes that regulate the sleep-wake cycle and other physiological functions over a 24-hour period. Governed by an internal biological clock located in the suprachiasmatic nucleus of the brain, these rhythms influence sleep, hormone release, eating habits, and body temperature. Light exposure plays a crucial role in synchronizing circadian rhythms, signaling the body when to be awake or asleep.

Disruptions to these rhythms, often caused by irregular sleep patterns, shift work, or exposure to artificial light, can lead to sleep disorders, metabolic issues, and mood disturbances. Maintaining a consistent sleep schedule and minimizing exposure to blue light at night can help support healthy circadian rhythms, ultimately enhancing overall well-being and productivity.

Track-19: Menstrual Irregularities

Menstrual irregularities refer to variations in the menstrual cycle, including changes in frequency, duration, and flow. Common forms include amenorrhea (absence of periods), oligomenorrhea (infrequent periods), and menorrhagia (heavy bleeding). These irregularities can be caused by various factors, such as hormonal imbalances, stress, excessive exercise, weight fluctuations, and medical conditions like polycystic ovary syndrome (PCOS) or thyroid disorders.

Lifestyle factors, including diet and stress levels, can also influence menstrual patterns. While occasional irregularities may not be a cause for concern, persistent changes should be evaluated by a healthcare provider to identify underlying issues. Managing menstrual irregularities often involves lifestyle adjustments, medication, or hormone therapy, aimed at restoring a regular cycle and improving overall reproductive health.

Track-20: Digital Health

Digital health in endocrinology is transforming patient care and management through innovative technologies. Telemedicine allows endocrinologists to monitor patients with diabetes, thyroid disorders, and other hormonal issues remotely, improving access to specialized care. Mobile health applications enable patients to track their blood glucose levels, medication adherence, and lifestyle changes in real-time, fostering greater engagement in their own health. Wearable devices provide continuous data on vital signs and glucose levels, aiding in personalized treatment plans. Furthermore, artificial intelligence enhances diagnostic accuracy and predictive analytics, allowing for timely interventions. Overall, digital health not only streamlines clinical workflows but also empowers patients, ultimately leading to improved health outcomes in endocrinology.

Market Analysis

Importance & Scope:

In 2012 there were 1.5 million deaths worldwide directly caused by diabetes. It was the eighth leading cause of death among both sexes and the fifth leading cause of death in women in 2012. Blood glucose levels that are higher than optimal, even if below the diagnostic threshold for diabetes, are a major source of mortality and morbidity. The diagnostic criterion for diabetes is fasting plasma glucose ≥ 7.0 mmol/L – a diagnostic point selected on the basis of microvascular complications such as diabetic retinopathy. The risk of macro-vascular diseases, such as heart attack or stroke, however, starts increasing well before this diagnostic point. To better understand the full impact of blood glucose levels on mortality, therefore, requires a look at mortality related to blood glucose as a risk factor. The total burden of deaths from high blood glucose1 in 2012 has been estimated to amount to 3.7 million. This number includes 1.5 million diabetes deaths, and an additional 2.2 million deaths from cardiovascular diseases, chronic kidney disease, and tuberculosis related to higher-than-optimal blood glucose. Its magnitude highlights that high blood glucose causes a large burden of mortality beyond those deaths directly caused by diabetes. The largest number of deaths resulting from high blood glucose occurs in upper-middle-income countries (1.5 million) and the lowest number in low-income countries (0.3 million). After the age of 50, middle-income countries have the highest proportion of deaths attributed to high blood glucose, for both men and women.

Except in high-income countries, the proportion of deaths attributable to high blood glucose for both men and women are highest in the age group 60–69 years. Forty-three percent of all deaths attributable to high blood glucose occur prematurely, before the age of 70 years – an estimated 1.6 million deaths worldwide. Globally, high blood glucose causes about 7% of deaths among men aged 20–69 and 8% among women aged 20–69.

The endocrine system is a network of glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a vital role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders.

High blood glucose kills about 3.4 million people worldwide, annually. More than 80% of these deaths occur in low- and middle-income countries, and almost half are people aged less than 70 years. Diabetes deaths will be doubled between 2005 and 2030, as per WHO projections.

WHO Region	Both sexes	Female	Male
African Region	111.3	110.9	111.1
Region of the Americas	72.6	63.9	82.8
Eastern Mediterranean Region	139.6	140.2	138.3
European Region	55.7	46.5	64.5
South-East Asia Region	115.3	101.8	129.1
Western Pacific Region	67	65.8	67.8

The prevalence of endocrine disorders is increasing among all ages in Europe, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. About 60 million people with diabetes in the European Region and about 10.3% of men and 9.6% of women aged 25 years and over.

The incidence and prevalence of diabetes has been increasing in countries throughout the world. This situation is clearly reflected in the recently published data from the NCD-RisC (Non-Communicable Diseases Risk Factors Collaboration) study, showing that the number of individuals with diabetes quadrupled between 1980 and 2014, particularly in developing countries. United Kingdom has not escaped this upward trend. The Diabetes study reported an age- and sex-adjusted total prevalence of 13.8%, and almost half the affected individuals (6%) were unaware of their condition. Furthermore, the expectations for the future are not reassuring: The International Diabetes Federation has estimated that this disease will affect 642 million adults aged 18 to 79 years in 2040 (this same organization established the value at 415 million in 2015), and approximately 90% of them will have diabetes type. Since 7% to 14% of their current budget is allocated to the treatment of this disease. Recent studies in Europe4 have shown that patients with diabetes consume twice the amount of health care resources as the nondiabetic population, and the cost increases as patients develop chronic complications. There are several reasons for the rise in the incidence and prevalence of this condition, such as increases in the dual epidemic of excess weight and obesity5 and in sedentary lifestyles, as well as population aging.

One key factor related to the higher prevalence is the improvement in survival prompted by various therapies that enable better glycemic control, and especially, control of cholesterol levels and hypertension. Diabetes is associated with considerable morbidity and mortality, mainly of cardiovascular origin. More than 75% of hospitalizations and more than 50% of deaths in this population are due to cardiovascular causes, as has been extensively reported. The Steno-2 study showed that intensive, multifactorial management of hyperglycemia, hypercholesterolemia, and hypertension, together with antiplatelet therapy, result in effective reductions in vascular complications and mortality in the type 2 diabetes population, with decreases of 57% in cardiovascular deaths and 46% in overall mortality. In a recent update of that study, intensive treatment during the first 7 or 8 years was associated with a mean increase in life expectancy of 7.9 years after a follow-up period of 21 years.6

Member Associated with Diabetes and Endocrinology Research:

To support, instruct, redesign and prepare enrolled restorative experts, dieticians, qualified medical caretakers and other properly qualified paramedical staff in the field of Diabetes different surely understood social orders/affiliations are working over the globe to effectively avert and battle the deadly infection.

The European Society of Endocrinology (ESE) is a logical society to advance for people in general advantage exploration, instruction and clinical practice in endocrinology by the association of meetings, instructional classes and productions, by raising open mindfulness, contact with national and worldwide officials.

Market value on Diabetic Research:

This measurement shows the main ten pharmaceutical organizations in view of worldwide hostile to diabetic income in 2014 and a projection for 2020, in million U.S. dollars. In 2014, Merck and Co created around six billion U.S. dollars in against diabetic income and is required to create more than eight billion U.S. dollars by 2020. Hostile to diabetic prescription is regularly ingested orally, except for insulin, exenatide, liraglutide, and pramlintide. Drugs used to treat diabetes mellitus are frequently called oral hypoglycemic specialists or oral antihyperglycemic operators.

No.Of Diabetic Effected Persons (Prevalence rate)

Major Associations of Endocrinology and Diabetes around the Globe

Key players in Endocrinology and Diabetes

The top universities having the Endocrinology and Diabetes department:

Societies Associated with Endocrinology and Diabetes Research

Hospitals for endocrinology and diabetes care

DISCLAIMER
The information developed in this report is intended only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

Accreditation

All major Conference Series Conferences are accredited with Continuing Education (CE), Continuing Professional Development (CPD) and Continuing Medical Education (CME) credits respectively.

CME Credits:

Continuing Medical Education (CME) refers to a specific form of continuing education that helps medical professionals to maintain competence and learn about new and developing areas of their field. Conference Series Conferences are recognised and accredited with CME credits to enhance the professional abilities and skills of participants. CME credits are important to physicians because they require a specified number of credits annually to maintain medical licenses. CME credits are authorized by the Accreditation Council for Continuing Medical Education. Attending CME accredited conference is beneficial and valuable to physicians and other medical professional as it is a source of constant improvement that ultimately improves their medical practice, and keeps them up-to-date on the latest technologies, advancements, treatments, etc. Speaking at CME activities can also be a great stage for clinical medical professionals to share their expertise and increase their distinction in their specialty.

CE Credits:

Continuing Education (CE) credit is a measure used in continuing education programs to assist the professional to maintain his or her license in their profession. Conference Series Conferences provides ample opportunities to acquire CE credits. CE can open up previously closed doors and lead to better job opportunities. CE usually refers to college courses or other vocational training obtained by older adults or working professionals. CE credits work as carrier promoter and hold great value in medical, clinical and other areas of research even after completion of degrees in concerned field of research. It is pivotal in today’s world to get updated information on your field of research and profession. Attending Continuing Education Conferences can help expand your network and make connections that could translate into profitable relationships or job opportunities down the line. It also plays a vital role in recruiting new team members for an employer with open positions. CE helps licensing organizations and professional membership groups. Continuing Education promotes high quality performance, keep professionals up to date with the latest advances, and provide excellent networking opportunities.

CPD Credits:

Continuing Professional Development (CPD) is the holistic commitment of professionals towards the enhancement of personal skills and proficiency throughout their careers. It enables learning to become conscious and proactive, rather than passive and reactive. CPD accreditation is important because it ensures that courses provided adhere to the highest educational standards and international benchmarks of quality and learning. CPD enriches your knowledge, keeps you currently competent and is the key to career progression and professional growth. There are many advantages to carrying out CPD that includes filling gaps in your knowledge and skills to become more productive and efficient, building confidence and credibility to stand out from the crowd, achieving your career goals and demonstrating professional status. CPD hours can be earned through continuing education, leadership activities, instructional activities, completion of significant work projects, research and publications. Conference Series Conferences have been accredited with CPD credits to expedite the progress of research and industry professionals.

Past Conference Report

Euro Endocrinology 2023 hosted by Conference Series llc ltd took place during November 20-21, 2023 in Dubai, UAE. It was organized by Conference Series llc ltd and generous response was received from the Editorial Board Members of international Journals as well as from eminent scientists, talented researchers and the young student community. Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2023. The two days program witnessed thought-provoking keynote and plenary presentations from experts in the field of Diabetes and Endocrinology.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

The highlights of the meeting were the keynote lectures from

Halyna Loi, I.Horbachevsky Ternopil National Medical University, Ukraine
Gerald C. Hsu, eclaire MD Foundation, USA
Masao Kaneki, Harvard Medical School, USA

Euro Endocrinology 2023 played an important role in promoting multidisciplinary interactions between science and medicine to enhance research in Diabetes and Endocrinology. The program covered current and emerging research innovations in the field of Diabetes and Endocrinology.
We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Euro Endocrinology 2022 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, We would like to announce the commencement of the " 18^th European Diabetes and Endocrinology Congress" during March 10-11, 2025 which will be held in Rome, Italy.

Let us meet again @ Euro Endocrinology 2025